HOME › Press Releases › Respiratory Care Devices Market worth 21.9 Billion USD by 2020
Respiratory Care Devices Market worth 21.9 Billion USD by 2020
The report “Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables & Accessories), by End User (Hospital, Home Care) - Global Forecast to 2020”,the global respiratory care devices market is estimated to reach USD 21.9 Billion by 2020 at a CAGR of 9.6% during the forecast period of 2015 to 2020
Browse 190 tables and 44 figures spread through 240 Pages and in-depth TOC on "Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables & Accessories), by End User (Hospital, Home Care) - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
The respiratory care devices market is growing at a significant rate since the last decade. Growth in this market is mainly attributed to the high prevalence of respiratory diseases, rising aging population across the globe, high prevalence of smoking, rising urbanization and pollution levels, increasing incidences of preterm births, and lifestyle changes. However, lack of awareness and harmful effects of certain respiratory care devices on neonates are the major challenges in this market.
In this report, the respiratory care devices market is segmented on the basis of products and end users. On the basis of products, the respiratory care devices market is segmented into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. The therapeutic devices segment is further divided into humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, reusable resuscitators, ventilators, inhalers, masks, nitric oxide delivery units, and oxygen hoods. The monitoring devices segment is categorized into pulse oximeters, capnographs, and gas analyzers. The diagnostics devices segment is subdivided into spirometers, peak flow meters, polysomnography (PSG) devices, and other diagnostic devices; while, the consumables and accessories segment is categorized into disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas, and other consumables & accessories.
In 2014, the therapeutic devices segment accounted for the largest share of the global respiratory care devices market. The large share of this segment is mainly attributed to the rising adoption of various therapeutic devices such as nebulizers, oxygen concentrators, humidifiers, and PAP devices due to growth in the elderly population and rising prevalence of respiratory diseases.
On the basis of end users, the respiratory care devices market is bifurcated into hospitals and home care. Hospitals are the major end users of the global respiratory care devices market, owing to the financial capabilities of hospitals to purchase high-end instruments as well as the availability of trained professionals to operate respiratory care devices.
On the basis of regions, the respiratory care devices market is broadly segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Highly developed healthcare systems and rising healthcare expenditures are the major factors responsible for the large shares of North America and Europe in the global respiratory care devices market. However, the Asia-Pacific region is expected to grow at the highest CAGR, owing to the presence of a large pool of respiratory patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita incomes, and growing middle-class population in emerging countries of this region.
Major players in the global respiratory care devices market include Philips Healthcare (Netherlands), ResMed, Inc. (U.S.), Covidien plc (Ireland), Masimo Corporation (U.S.), Fisher and Paykel Healthcare Limited (New Zealand), and CareFusion Corporation (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India